| # | Drug | Count |
|---|---|---|
| 0 | ONABOTULINUMTOXINA | 11 |
| 1 | MINOXIDIL | 6 |
| 2 | MINOXIDIL FOAM 5% (WOMENS) | 6 |
| 3 | TRIAMCINOLONE ACETONIDE | 6 |
| 4 | TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% | 6 |
| 5 | CLOBETASOL PROPIONATE | 5 |
| 6 | CLOBETASOL PROPIONATE OINTMENT USP, 0.05% | 5 |
| 7 | ISOTRETINOIN | 5 |
| 8 | BUPIVACAINE | 4 |
| 9 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ROPEGINTERFERON ALFA-2B | 2 | 0.0011 |
| 1 | MEPIVACAINE HYDROCHLORIDE | 1 | 0.0009 |
| 2 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | 4 | 0.0005 |
| 3 | CLOBETASOL PROPIONATE OINTMENT USP, 0.05% | 5 | 0.0005 |
| 4 | CLOBETASOL PROPIONATE | 5 | 0.0005 |
| 5 | BUPIVACAINE | 4 | 0.0004 |
| 6 | TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% | 6 | 0.0002 |
| 7 | TRIAMCINOLONE ACETONIDE | 6 | 0.0002 |
| 8 | ONABOTULINUMTOXINA | 11 | 0.0001 |
| 9 | MINOXIDIL | 6 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Acetylcholine Release Inhibitor [EPC] | 11 |
| 1 | Neuromuscular Blocker [EPC] | 11 |
| 2 | Corticosteroid [EPC] | 8 |
| 3 | 5-alpha Reductase Inhibitor [EPC] | 6 |
| 4 | Amide Local Anesthetic [EPC] | 6 |
| 5 | Arteriolar Vasodilator [EPC] | 6 |
| 6 | Retinoid [EPC] | 5 |
| 7 | Cytolytic Agent [EPC] | 4 |
| 8 | Interferon beta [EPC] | 3 |
| 9 | Interleukin-4 Receptor alpha Antagonist [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytolytic Agent [EPC] | 4 | 0.0017 |
| 1 | Interferon alfa-2b [EPC] | 2 | 0.0011 |
| 2 | Acetylcholine Release Inhibitor [EPC] | 11 | 0.0001 |
| 3 | Arteriolar Vasodilator [EPC] | 6 | 0.0001 |
| 4 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |
| 5 | Amide Local Anesthetic [EPC] | 6 | 0.0001 |
| 6 | Interleukin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 7 | 5-alpha Reductase Inhibitor [EPC] | 6 | 0.0001 |
| 8 | PCSK9 Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |